CSI Market
Sign In | Register

Cv Sciences Inc (CVSI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CVSI Annual Cash Flow →
Quarterly cash flow trends provide additional context on Cv Sciences Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.42
Depreciation & amortization0.05
Amortization of Other Assets0.10
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.11
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.30
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.02
Note Receivable Issued On Litigation Settlement-
Amortization Of Beneficial Conversion Feature Of Convertible Debt-
Gain On Collection Of Related Party Notes Receivable-
Derivative Gain Loss On Derivative Net-
Amortization Of Derivative Liability Discount-
Royalty Expense-
Gain Loss On Derivative Instruments Net Pretax-
Stockbased Compensation Employment Settlement-
Impairment Of Tax Receivable For R S U Settlement-
Gain Loss On Termination Of Lease-
Employee Retention Credit Benefit-
Purchase Of Insurance Through Issuance Of Note Payable-
Debt Discount And Interest Expense-
Operating Lease Right Of Use Asset Amortization Expense0.18
Payroll Tax Expense Reversal-0.52
Gain Loss In Fair Value Of Contingent Consideration Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.07
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.18
Increase (Decrease) in Interest Payable, Net0.00
Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.06
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.14
Discontinued operations0.00
Net Cash flow from Operating Activities0.12
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Payments for Leasing Costs, Commissions, and Tenant Improvements0.00
Repayment Of Principal On Note Receivable-
Repayment Of Notes Receivable-
Note Receivable From Legal Settlement-
Issuance Of Note Receivable-
Payments To Tenantleasehold Incentive-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.02
Long-term debt - borrowings0.00
Long-term debt - repayments-0.11
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayment Of Loan To Roen Ventures-
Common Stock To Be Issued Cash Flow-
Issuance Of Note Payable From Vendor-
Repayments Of Convertible Debt In Cash-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.45
Proceeds From Issuance Of Preferred Stock And Common Stock Warrants Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.12
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.11
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Cv Sciences Inc cash flow history.

Sign In Create Free Account

About Cv Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-349211

Figures are derived from filed reports and may be restated. Historical data is subject to revision.